Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Gateway, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Gateway patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Gateway: Texas Weight Loss - North Austin, Texas Weight Loss - South Austin and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
For Gateway residents, the essentials on tirzepatide. Sold as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide stands out for its unique dual-hormone mechanism.
A good prescriber also explains the exit plan: what to do with the dose if you want to stop. A prescription requires a clinician licensed to practice in the patient's state: they validate the indication and set the starting dose.
In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board. On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. depending on the format (brand vs compounded). For a Gateway resident, Tirzepatide is now largely managed remotely, home delivery included. Associated brands include Mounjaro, Zepbound.
A physician or authorized practitioner (depending on the state) after evaluation; in telehealth, that practitioner must be licensed in the patient's state of residence.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.